Other Information.
−Removed: On August 8, 2022, William Forbes, our Chief Development Officer, notified us that he would be stepping down, effective September 1, 2022.
−Removed: Forbes has agreed to continue to serve as a consultant to us following the termination of his employment with us.
+Added: On October 25, 2022, we and Dr.
+Added: Thomas Sciascia, our Chief Medical Officer, agreed that effective November 14, 2022, Dr.
+Added: Sciascia would cease to serve as our Chief Medical Officer and would instead begin to serve as our Chief Scientific Officer.
Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-38886) filed with the SEC on April 7, 2022)
−Removed: Amendment No.
−Removed: 1 to the Sales Agreement, dated May 13, 2022, by and between the Registrant and SVB Securities LLC (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-38886) filed with the SEC on May 16, 2022)
−Removed: Securities Purchase Agreement, dated April 6, 2022, by and among the Registrant and the Purchasers named therein (incorporated by reference to Exhibit 99.1 to the Registrant’s Current Report on Form 8-K (File no.
−Removed: 001-38886) filed with the SEC on April 7, 2022)
−Removed: Registration Rights Agreement, dated April 6, 2022, by and among the Registrant and the Purchasers named therein (incorporated by reference to Exhibit 99.2 to the Registrant’s Current Report on Form 8-K (File no.
−Removed: 001-38886) filed with the SEC on April 7, 2022)
−Removed: Third Amendment to Loan and Security Agreement, dated April 6, 2022, by and between Silicon Valley Bank and the Registrant (incorporated by reference to Exhibit 99.3 to the Registrant’s Current Report on Form 8-K (File no.
−Removed: 001-38886) filed with the SEC on April 7, 2022)
+Added: 001-38886) filed with the Securities and Exchange Commission on September 23, 2022)
+Added: Consulting Services Agreement, dated August 31, 2022, by and between the Registrant and William P.
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
14 unchanged sentences
TREVI THERAPEUTICS, INC.
−Removed: August 11, 2022
+Added: November 10, 2022
/s/ Jennifer L.
5 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.